|
PB 12 of 2014
Arrangements as made
|
|
This instrument amends the National Health (Efficient Funding of Chemotherapy) Special Arrangement 2011 (No. PB 79 of 2011) to remove 16 listed brands for the listed drugs ‘Carboplatin’, ‘Cisplatin’, ‘Epirubicin’, ‘Fludarabine’, ‘Gemcitabine’, ‘Irinotecan’, ‘Mitozantrone’, ‘Oxaliplatin’ and ‘Paclitaxel’.
|